SCHEMBL18135548

SCHEMBL18135548

Cc1ccc(OCCN2CCN(c3nc(N)n[nH]3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHIT1 Q13231 1/20 0.52
▸ CHIA Q9BZP6 1/20 0.52
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ NR2F2 P24468 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ACHE P22303 3/20 0.46
▸ KCNA5 P22460 6/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.45
▸ GAA P10253 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ DRD2 P14416 2/20 0.45
▸ HTR1A P08908 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16825820 0.90 CHIT1 (0.52) CHIT1CHIAKCNA5GAANPC1
SCHEMBL16825821 0.88 CHIT1 (0.52) CHIT1CHIALMNAMAPTSMN1; SMN2
SCHEMBL16825681 0.88 CHIT1 (0.52) CHIT1CHIALMNAMEN1HTT
SCHEMBL16826340 0.88 CHIA (0.67) CHIT1CHIAKMT2AKCNA5GAA
SCHEMBL16825744 0.88 CHIT1 (0.51) CHIT1CHIAKCNA5DRD2HTR1A
SCHEMBL16825716 0.84 CHIA (0.62) CHIT1CHIAACHEDRD3KDM4E
SCHEMBL16825773 0.83 SLC6A2 (0.61) CHIT1CHIAHRH3DRD2DRD3
SCHEMBL16826405 0.81 DRD2 (0.59) HRH3DRD2HTR1ADRD3
SCHEMBL16825679 0.81 HTR1A (0.54) DRD2HTR1ADRD3
SCHEMBL16826343 0.80 LTA4H (0.64) CHIT1CHIAMAPTDRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME CMA1, CHIA, AADAC CHIT1 11/4885CHIA 2/4885LMNA 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback